In consideration of the data obtained within this study, the anti-apoptotic PI3K/AKT pathway is a good candidate, which is additionally supported by the fact that its inhibition is synergistic with RAF inhibitors to block proliferation in thyroid cancer cell lines [59]. This evidence concerns the gene RAF1 and thyroid gland carcinoma.